PFIZER
Back to Income Statement
|
PFIZER Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,281 Cr | ₹2,193 Cr | ₹2,425 Cr | ₹2,611 Cr | ₹2,239 Cr |
What is the latest Revenue of PFIZER ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,281 Cr |
| Mar2024 | ₹2,193 Cr |
| Mar2023 | ₹2,425 Cr |
| Mar2022 | ₹2,611 Cr |
| Mar2021 | ₹2,239 Cr |
How is Revenue of PFIZER Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,281 Cr | 4.02 | |
| Mar2024 | ₹2,193 Cr | -9.55 | |
| Mar2023 | ₹2,425 Cr | -7.13 | |
| Mar2022 | ₹2,611 Cr | 16.64 | |
| Mar2021 | ₹2,239 Cr | - | |
Compare Revenue of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹22,335.0 Cr | -1.4% | -1.8% | -6.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,929.0 Cr | 0.7% | -4.2% | -8.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,644.0 Cr | 0% | -1% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹131,481.0 Cr | 2.4% | 4.5% | 14.5% | Stock Analytics | |
| CIPLA | ₹122,050.0 Cr | 1.1% | 0.2% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,784.0 Cr | -1% | -2% | -9.7% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | -1.4% |
-1.8% |
-6.8% |
| SENSEX | 0.9% |
0.7% |
9.6% |
You may also like the below Video Courses